OneSource Specialty Pharma Ltd Share Price (ONESOURCE)
Check the latest share price of OneSource Specialty Pharma Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
OneSource Specialty Pharma Ltd Stock Performance
Get live OneSource Specialty Pharma Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹1,906.1Day's Price Range₹2,030.152 Week's Low
52 Week's High
₹1,209.9552-Week Price Range₹2,115
| Returns % | |
| 1 Month Return | + 26.64 % |
| 3 Month Return | + 37.94 % |
| 1 Year Return | + 18.44 % |
| 3 Year Return | + 18.44 % |
| 5 Year Return | + 18.44 % |
| Market Stats | |
| Previous Close | ₹1,976.70 |
| Open | ₹1,907.50 |
| Volume | 2.06L |
| Upper Circuit | ₹2,372.00 |
| Lower Circuit | ₹1,581.40 |
OneSource Specialty Pharma Ltd Fundamentals & Key Indicators
Check OneSource Specialty Pharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹6.24 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Industry PE ratio
57.39
Beta (LTM)
0.32
P/B Ratio
-0.04
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-345.21
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
How to invest in OneSource Specialty Pharma Ltd?
Investing in OneSource Specialty Pharma Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for OneSource Specialty Pharma Ltd or ONESOURCE on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of OneSource Specialty Pharma Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like OneSource Specialty Pharma Ltd with just a few clicks!
OneSource Specialty Pharma Ltd Stock's Interest Amongst Investors
OneSource Specialty Pharma Ltd Valuation
Track how OneSource Specialty Pharma Ltd P/E has moved over time to understand its valuation trends.
OneSource Specialty Pharma Ltd in the last 5 years
Lowest (-130.42x)
June 11, 2025
Today (-128.75x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (-36.41x)
February 28, 2025
Today’s Price to Earnings Ratio: -128.75x
OneSource Specialty Pharma Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on OneSource Specialty Pharma Ltd.
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for OneSource Specialty Pharma Ltd. Average target price of ₹2056.5
Source: S&P Global Market Intelligence
OneSource Specialty Pharma Ltd Share Price Target
Get share price movements and forecasts by analysts on OneSource Specialty Pharma Ltd.
OneSource Specialty Pharma Ltd price forecast by 2 analysts
Upside of1.54%
High
₹2113
Target
₹2056.50
Low
₹2000
OneSource Specialty Pharma Ltd target price ₹2056.5, a slight upside of 1.54% compared to current price of ₹2025.3. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
OneSource Specialty Pharma Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
OneSource Specialty Pharma Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
OneSource Specialty Pharma Ltd Financial Results
Get the annual and quarterly financial summary of OneSource Specialty Pharma Ltd, including revenue, profit, loss and more.
OneSource Specialty Pharma Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of OneSource Specialty Pharma Ltd.
OneSource Specialty Pharma Ltd Earnings Results
OneSource Specialty Pharma Ltd’s net profit jumped 345.21% since last year same period to ₹98.50Cr in the Q4 2024-2025. On a quarterly growth basis, OneSource Specialty Pharma Ltd has generated 243.06% jump in its net profits since last 3-months.
Read More about Earnings Results
OneSource Specialty Pharma Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in OneSource Specialty Pharma Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 34.25% | 0.00 | |
| Foreign Institutions | 18.54% | 0.00 | |
| Mutual Funds | 8.32% | 0.00 | |
| Retail Investors | 29.17% | 0.00 | |
| Others | 9.72% | 0.00 |
OneSource Specialty Pharma Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of OneSource Specialty Pharma Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 6.24 | 5.19% | 5.69 | NA | NA | |
| NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
| NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
| NA | 69.91 | 6.88% | 0.78 | 2 | 45 | |
| NA | 375.28 | 30.71% | 0.51 | NA | NA |
OneSource Specialty Pharma Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in OneSource Specialty Pharma Ltd.
OneSource Specialty Pharma Anticipates Strong Growth - 12 Jun, 2025
OneSource Specialty Pharma expects significant growth in its order book over the next three years, driven by rising demand for weight-loss drugs. The company added 15 orders related to obesity and diabetes drugs in fiscal year 2025 and anticipates a 30% compound annual growth rate through fiscal year 2028.OneSource Partners with Xbrane, Reports Strong Q4 Results - 11 Jun, 2025
OneSource Specialty Pharma announced a partnership with Xbrane Biopharma for biosimilar manufacturing, enhancing regulatory approvals. The company reported a net profit of Rs 98.50 crore in Q4 March 2025, a significant turnaround from a loss in the previous year, with net sales surging 482.38% YoY.OneSource Secures VAI Classification from USFDA - 10 Jun, 2025
OneSource Specialty Pharma's Bangalore facility received a Voluntary Action Indicated (VAI) classification from the USFDA, confirming compliance after a recent inspection. This positive outcome is crucial for the company's manufacturing capabilities and future product launches.Delhi High Court Restrains OneSource from Marketing Semaglutide - 01 Jun, 2025
The Delhi High Court has prohibited Dr. Reddys Laboratories and OneSource Specialty Pharma from selling or marketing the diabetes and anti-obesity drug semaglutide, impacting their operations.Onesource Specialty Pharma Expands Capacity and Revenue - 30 May, 2025
Onesource Specialty Pharma is scaling up capacity and developing complex products, expecting significant revenue growth driven by new projects and strong customer demand. Revenue rose 33% to ₹1,445 crore in FY25, with a net profit of ₹93 crore. The company anticipates a CAGR of over 30% through FY28, supported by increased operational efficiency and expansion into high-value biologics and drug-device combinations.
Insights on OneSource Specialty Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 17.44% to 18.54% in Mar 2025 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 4.62% to 8.32% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, ONESOURCE stock has moved up by 26.6%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 32.23% to 29.17% in Mar 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 37.77% to 34.25% in Mar 2025 quarter
About OneSource Specialty Pharma Ltd
Revenue: ₹425.95Cr as on March 2025 (Q4 FY25)
Net Profit: ₹98.50Cr as on March 2025 (Q4 FY25)
Listing date: 24 Jan, 2025
| Organisation | OneSource Specialty Pharma Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Mutual Funds that own OneSource Specialty Pharma Ltd
Check out the Mutual Funds with significant holdings in OneSource Specialty Pharma Ltd.
FAQs
What is OneSource Specialty Pharma Ltd share price today?
OneSource Specialty Pharma Ltd share price today stands at ₹2025.3, Open: ₹1907.5, Previous Close: ₹1976.7, High: ₹2030.1, Low: ₹1906.1, 52 Week High: ₹2115, 52 Week Low: ₹1209.95.
What is today's traded volume of OneSource Specialty Pharma Ltd?
Today's traded volume of OneSource Specialty Pharma Ltd is 2.06L. Which means that 2.06L shares of OneSource Specialty Pharma Ltd were bought and sold on the stock market during today's trading session.
What is OneSource Specialty Pharma Ltd's market cap today?
Today's market capitalisation of OneSource Specialty Pharma Ltd is ₹23,176.73 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of OneSource Specialty Pharma Ltd?
OneSource Specialty Pharma Ltd’s 52 week high is ₹2115 and 52 week low is ₹1209.95. The current share price of OneSource Specialty Pharma Ltd is ₹2025.3, which is -4.24% down from its 52 week high and 67.39% up from its 52 week low.